Примери за използване на Frequency categories на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The frequency categories used are.
Adverse reactions are listed in Table 1 according to MedDRA system organ class and frequency categories.
Frequency categories are as follows.
The adverse reactions are assigned frequency categories using the following convention: Very Common(≥1/10);
Frequency categories are expressed as.
Based on a PRAC request, the MAH has reconsidered the frequency categories of Fanconi syndrome and proximal renal tubulopathy in the SmPC for Hepsera.
Frequency categories are defined using the following convention.
The MAH, as requested, re-calculated the adverse reactions(ARs) frequency categories for those reactions identified from post-marketing data to take into account the revised SPC guidelines.
Frequency categories are defined according to the following conventions.
Table 1 presents adverse reactions listed by system organ class and frequency categories, using the following convention: very common(≥1/10), common(≥1/100 to< 1/10), and uncommon(≥1/1,000 to< 1/100), and not known.
Frequency categories are defined as: very common(≥ 1/10) and common(≥ 1/100 to< 1/10).
Tabulated list of adverse reactions Table 2 presents adverse reactions listed by system organ class and frequency categories, using the following convention: very common(≥1/10), common(≥1/100 to< 1/10), uncommon≥1/1,000 to.
Frequency categories are based on information available from the metformin Summary of Product Characteristics.
The ADRs listed in Table 1 are presented by system organ class and frequency categories, defined using the following convention: very common(≥ 1/ 10); common(≥ 1/ 100 to< 1/ 10) or uncommon(≥ 1/ 1,000 to< 1/ 100).
Frequency categories for the events below have been based on clinical trials and postmarketing data.
While they may in reality occur at lower frequencies than indicated below,the size of the source database did not allow for the assignment of frequency categories lower than the category“uncommon”(≥1/1,000 to< 1/100).
Frequency categories below reflect combined data for the 2 doses of Eperzan, 30 mg or 50 mg weekly subcutaneously.
In the table below, since the majority of thestudies were of an open nature, all causality adverse reactions and their frequency categories in 1,873 adults from pooled therapeutic(1,603) and prophylaxis(270) studies, by system organ class.
Frequency categories are based on information available from metformin Summary of Product Characteristics available in the EU.
In the table below,since the majority of the studies were of an open nature all causality adverse reactions, and their frequency categories in 1,873 adults from pooled therapeutic(1,603) and prophylaxis(270) studies, by system organ classare listed.
Frequency categories are based on information available from metformin Summary of Product Characteristics available in the European Union.
The CHMP endorsed the MAH proposal after the frequency categories used in the SPC of Vascace Plus had been harmonised with the ones of the SPC for Vascace.
Frequency categories are defined as follows: very common(≥1/10), common(≥1/100 to< 1/10), not known.
Frequency categories are derived according to the following conventions: common(≥ 1/100 to< 1/10), uncommon(≥ 1/1,000 to< 1/100)(see Table 3).
Frequency categories do not account for other factors including varying study duration, pre-existing conditions and baseline patient characteristics.
The frequency categories in the table are based on studies in adults; the observed frequencies in the paediatric studies were similar or lower.
Frequency categories were determined from the crude incidence rate reported for each adverse reaction in a dataset of pooled clinical studies(n= 2,944).
Frequency categories do not account for other factors including varying study duration, pre-existing conditions and baseline patient characteristics.
Frequency categories do not account for other factors including varying study duration, pre-existing conditions and baseline patient characteristics.
Frequency categories were determined from the crude incidence rate reported for each adverse reaction in clinical studies of patients with B-precursor ALL(N= 843).